• Poteligeo Proves Safe, Effective for ATL Patients in Clinical Setting
  • Opdivo Effective for Relapsed/Refractory Classical Hodgkin’s Lymphoma, Meta-analysis Suggests
  • European Commission Approves Adcetris/Chemo Combo for Some Hodgkin’s
  • FDA Update Shows 457 Cases of ALCL Linked to Breast Implants
  • Stand Up To Cancer’s ‘Dream Team’ to Investigate Devimistat Combo Therapy for T-cell Lymphoma
  • Experts Propose New Consensus Scale for CAR T-cell Therapy Toxicities
  • Rituxan Plus Chemo Fails to Benefit Newly Diagnosed Primary CNS Lymphoma Patients in Clinical Trial
  • U.K. Institute Recommends Kymriah for Adults with Aggressive DLBCL
  • The Joy of a New Oncologist
  • Stand Up To Cancer’s ‘Dream Team’ of Experts Working on New Therapies for T-cell Lymphoma
  • BI-1206 Earns Orphan Drug Designation as Mantle Cell Lymphoma Treatment
  • Round Table Pizza to Raise Funds for Leukemia & Lymphoma Society on National Pizza Day